LYMPHOPENIA IS AN INDEPENDENT RISK-FACTOR IN PATIENTS WITH LOW-RISK MDS ACCORDING TO THE IPSS-R

被引：0
|
作者：
Silzle, T. [1 ]
Schuler, E. [2 ]
Hildebrandt, B. [3 ]
Blum, S. [4 ]
Haas, R. [2 ]
Germing, U. [2 ]
机构：
[1] Cantonal Hosp St Gallen, Oncol Haematol, St Gallen, Switzerland
[2] Univ Hosp Dusseldorf, Dept Haematol Oncol & Clin Immunol, Dusseldorf, Germany
[3] Univ Hosp Dusseldorf, Inst Human Genet, Dusseldorf, Germany
[4] CHU Vaudois, Dept Oncol, Lausanne, Switzerland
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P664
引用
收藏
页码：263 / 263
页数：1
相关论文
共 50 条
  • [1] Lymphopenia is highly prevalent in MDS and provides prognostic information for IPSS-R (very)-low-risk patients. An analysis from the EU-MDS registry
    Silzle, T.
    Taylor, A.
    de Witte, T.
    Malcovati, L.
    Fenaux, P.
    Bowen, D.
    Symeonidis, A.
    Stauder, R.
    Cermak, J.
    Sanz, G.
    Hellstrom-Lindberg, E.
    Langemeijer, S.
    Holm, M. Skov
    Madry, K.
    Tatic, A.
    de Almeida, A. Medina
    Savic, A.
    Smoljanovic, I. Mandac
    Germing, U.
    Smith, A.
    SWISS MEDICAL WEEKLY, 2021, 151 : 30 - 30
  • [2] New risk group staging according to new R-IPSS of 25 patients with low-risk MDS
    Tatic, A.
    Jardan, C.
    Georgescu, O.
    Stanca, O.
    Vasilica, M.
    Badelita, S.
    Crisan, A. M.
    Colita, A.
    Colita, D.
    Vulcan, G.
    Lupu, A. R.
    Coriu, D.
    LEUKEMIA RESEARCH, 2013, 37 : S98 - S99
  • [3] IMPACT OF TREATMENT ON OVERALL SURVIVAL IN PATIENTS WITH INTERMEDIATE-RISK MDS ACCORDING TO IPSS-R
    Perez Clara, Aparicio
    Rodriguez Elena, Paumard
    Ana Camila, Gonzalez Teomiro
    Camacho Inmaculada, Fernandez
    Hernandez Francisco, Salas
    Calvo Carmen, Martin
    Francisco Javier, Casano Sanchez
    Lopez Josefina, Serrano
    Garcia Joaquin, Sanchez
    HAEMATOLOGICA, 2021, 106 (10) : 250 - 250
  • [4] LYMPHOPENIA IS HIGHLY PREVALENT IN MDS AND PROVIDES ADDITIONAL PROGNOSTIC INFORMATION FOR IPSS-R VERY-LOW AND LOW-RISK PATIENTS. AN ANALYSIS FROM THE EU-MDS REGISTRY
    Silzle, T.
    Taylor, A.
    De Witte, T.
    Malcovati, L.
    Fenaux, P.
    Bowen, D.
    Symeonidis, A.
    Mittelman, M.
    Stauder, R.
    Cermak, J.
    Sanz, G.
    Hellstrom-Lindberg, E.
    Langemeijer, S.
    Holm, M. Skov
    Madry, K.
    Tatic, A.
    Almeida, A. Medina
    Savic, A.
    Rogulj, I. Mandac
    Germing, U.
    Smith, A.
    LEUKEMIA RESEARCH, 2021, 108 : S7 - S7
  • [5] Cytogenetic abnormalities in primary MDS: Incidence and classification according to cytogenetic risk groups defined by the IPSS and IPSS-R
    Silva, M.
    Azevedo Neto, R.
    Leal, A.
    Ferreira, P.
    Kumeda, C.
    Tanizawa, R.
    Mascarenhas, A.
    Lima, W.
    Buccheri, V.
    Velloso, E.
    LEUKEMIA RESEARCH, 2013, 37 : S71 - S71
  • [6] Lymphocytopenia at diagnosis is an independent risk-factor in patients with IPSSR-low-risk MDS
    Silzle, Tobias
    Blum, Sabine
    Schuler, Esther
    Rudelius, Martina
    Hildebrandt, Barbara
    Haas, Rainer
    Germing, Ulrich
    SWISS MEDICAL WEEKLY, 2019, 149 : 9S - 10S
  • [7] Transfusion dependency is associated with inferior outcome in very low- and low-risk IPSS-R patients
    Hiwase, D.
    Kutyna, M.
    Carr, T.
    Harrison, P.
    Melo, J. V.
    Bardy, P.
    To, L. B.
    LEUKEMIA RESEARCH, 2013, 37 : S78 - S79
  • [8] PROGNOSTIC IMPLICATION OF IPSS AND IPSS-R FOR PATIENTS WITH LOWER-RISK MDS TREATED WITH HYPOMETHYLATING AGENTS
    Moon, J. H.
    Sohn, S. K.
    Sook, A. Jae
    Kim, H. J.
    Song, M. K.
    Chung, J. S.
    Lim, S. N.
    Bae, S. H.
    HAEMATOLOGICA, 2014, 99 : 345 - 346
  • [9] CYTOGENETIC RISK STRATIFICATION ACCORDING TO IPSS-R IN PEDIATRIC MYELODYSPLASTIC SYNDROME
    Lovatel, V.
    Rodrigues, E.
    Otero, L.
    Kos, E.
    Da Siva, B.
    Tavares, R.
    Fonte, A.
    Bueno, A. P.
    Da Costa, E.
    Fernandez, T.
    LEUKEMIA RESEARCH, 2021, 108 : S21 - S21
  • [10] Revised IPSS (IPSS-R) stratification and outcome of MDS patients treated with azacitidine
    Massimo Breccia
    Adriano Salaroli
    Giuseppina Loglisci
    Giuliana Alimena
    Annals of Hematology, 2013, 92 : 411 - 412
12345